In the multicenter PIVENS ( PI oglitazone versus V itamin E versus placebo for the treatment of N onalcoholic S teatohepatitis) trial, 247 subjects with MASH but not diabetes mellitus were randomized to receive 30 mg/day of pioglitazone (an insulin-sensitizing drug), 800 IU/day (536 mg/day) of RRR --tocopherol, or a placebo for 96 weeks (97)
Lyttle MH, Docker MD, Hui HC, Caldwell CG, Aaron DT, Engqvist-Goldstein A, Flatgaard JE and Bauer KE
Also, if you buy our injectable-B12 vials, we provide detailed guidelines for SQ delivery
Emergency Preparedness : Ensure your provider carries emergency medications (epinephrine, antihistamines, corticosteroids) and has protocols for managing adverse reactions
This approach lets you assess individual response before adding complexity